View EO 12866 Meeting 1117-AB40

  Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have not had a Prior In-Person Medical Evaluation

  1117-DOJ/DEA

  Proposed Rule Stage

  07/11/2024 01:00 PM

  American Hospital Association   Jennifer Holloman


 
List of Documents
aha-comment-letter-to-dea-on-telemedicine-prescribing-of-controlled-substances-proposed-rule-3-29-23
hhs-rfi ensuring-patient-access-and-effective-drug-enforcement-8-23-2019
aha-comment-letter-to-dea-on-buprenorphine-telemedicine-prescribing-proposed-rule-3-29-23
Letter-to-DEA-Regarding-Request-for-Release-of-Special-Registration-for-Telemedicine-Regulation
 
List of Attendees Participation
•   Joe Nye  - OMB/OIRA Teleconference 
•   Jenna Bluestein  - ONDCP Teleconference 
•   Rachel Patterson  - DPC Teleconference 
•   Sreeja Kondeti  - OMB Teleconference 
•   Joshua Lipman  - DEA Teleconference 
•   Greg Aul  - DEA Teleconference 
•   Gianna Del Vecchio  - OMB Teleconference 
•   Lana Dundon  - DEA Teleconference 
•   Allison Villarivera  - DEA Teleconference 
•   Eric Gormsen  - DOJ Teleconference 
•   Heather Achbach  - DEA Teleconference 
•   Caitlin Gillooley  - American Hospital Association Teleconference 
•   Jennifer Holloman  - American Hospital Association Teleconference 
•   Joanna Hiatt Kim  - American Hospital Association Teleconference